Clinical Trial Update: A Study to Compare the Safety and Effectiveness of 2 Doses of Levofloxacin Given for Different Time Periods in Patients With Pneumonia [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing two dosing regimens of levofloxacin for pneumonia to evaluate safety and effectiveness has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• Levaquin (levofloxacin)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Pneumonia | Phase 3 | Status: COMPLETED